Latest News
Featured News
Notice of Interim Results and Investor Presentation
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present at the Next-Gen Immuno-Oncology Conference
Scancell Change of Auditor
Directorate Change and Appointment of Head of Development
Interim Results for the six months ended 31 October 2023
Notice of Interim Results and Presentation
MHRA approval to add a third cohort using iSCIB1+ to the SCOPE trial
15th Annual Protein & Antibody Summit Europe (PEGS), Lisbon, November 2023
Result of 2023 Annual General Meeting
Update on SCOPE trial
Notice of Annual General Meeting November 2023
Efficacy and safety results from the open-label Phase 2 SCOPE trial
Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.